StockNews.com began coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Free Report) (TSE:AEZ) in a note issued to investors on Thursday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock.
Aeterna Zentaris Stock Down 1.6 %
AEZS opened at $3.55 on Thursday. Aeterna Zentaris has a 52-week low of $3.96 and a 52-week high of $12.00. The company has a 50 day moving average of $4.04 and a two-hundred day moving average of $5.82. The company has a market cap of $6.37 million, a P/E ratio of -0.24 and a beta of 1.55.
Aeterna Zentaris Company Profile
Featured Stories
- Five stocks we like better than Aeterna Zentaris
- What Are Dividend Challengers?
- Boeing: Why Analysts Think Now’s The Time To Be Brave
- What is a Secondary Public Offering? What Investors Need to Know
- Advanced Micro Devices is Building Momentum with AI: Buy the Dip
- Dividend Capture Strategy: What You Need to Know
- Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?
Receive News & Ratings for Aeterna Zentaris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aeterna Zentaris and related companies with MarketBeat.com's FREE daily email newsletter.